Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Tumor-related epilepsy (TRE) is a frequent and major consequence of brain tumors.
Management of TRE is required throughout the course of disease and a deep …
Management of TRE is required throughout the course of disease and a deep …
Depression and anxiety in glioma patients
PB van der Meer, L Dirven, C Hertler… - Neuro-oncology …, 2023 - academic.oup.com
Glioma patients carry the burden of having both a progressive neurological disease and
cancer, and may face a variety of symptoms, including depression and anxiety. These …
cancer, and may face a variety of symptoms, including depression and anxiety. These …
Radiotherapy of high-grade gliomas: dealing with a stalemate
G Frosina - Critical reviews in oncology/hematology, 2023 - Elsevier
This article discusses the studies on radiotherapy of high-grade gliomas published between
January 1, 2022, and June 30, 2022, with special reference to their molecular biology basis …
January 1, 2022, and June 30, 2022, with special reference to their molecular biology basis …
Perampanel in brain tumor-related epilepsy: a systematic review
Brain tumor-related epilepsy (BTRE) is a common comorbidity in patients with brain
neoplasms and it may be either the first symptom or develop after the tumor diagnosis …
neoplasms and it may be either the first symptom or develop after the tumor diagnosis …
Antiepileptic strategies for patients with primary and metastatic brain tumors
HB Newton, J Wojkowski - Current Treatment Options in Oncology, 2024 - Springer
Opinion statement Seizure activity is common in patients with primary and metastatic brain
tumors, affecting more than 50% of cases over the course of their disease. Several …
tumors, affecting more than 50% of cases over the course of their disease. Several …
Disrupted glutamate homeostasis as a target for glioma therapy
M Biegański, M Szeliga - Pharmacological Reports, 2024 - Springer
Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS).
Gliomas, malignant brain tumors with a dismal prognosis, alter glutamate homeostasis in the …
Gliomas, malignant brain tumors with a dismal prognosis, alter glutamate homeostasis in the …
From bench to bedside: the application of cannabidiol in glioma
S Feng, Y Pan, P Lu, N Li, W Zhu, Z Hao - Journal of Translational …, 2024 - Springer
Glioma is the most common malignant tumor in central nervous system, with significant
health burdens to patients. Due to the intrinsic characteristics of glioma and the lack of …
health burdens to patients. Due to the intrinsic characteristics of glioma and the lack of …